MARIZYME INC (88) | Business Finance (45)

Browse by Subcategory

Recent Contracts

Agreement to Transfer Option and Amendatory Agreement, among Marizyme, Inc., James Sapirstein and Bevilacqua PLLC as escrow agent, dated March 3, 2022 (Filed With SEC on May 16, 2022)
Form of Class C Common Stock Purchase Warrant issued by Marizyme, Inc., dated May 11, 2022 (Filed With SEC on May 16, 2022)
Form of 10% Secured Convertible Promissory Note issued by Marizyme, Inc., dated May 11, 2022 (Filed With SEC on May 16, 2022)
Form of Guaranty, dated as of May 19, 2021, of Marizyme Sciences, Inc., Somaceutica, Inc., and Somahlution, Inc (Filed With SEC on February 14, 2022)
Mutual Release of Claims Agreement by and between Marizyme, Inc. and Nicholas DeVito dated August 27, 2020 (Filed With SEC on February 14, 2022)
Form of Guarantors Security Agreement, dated as of May 20, 2021, between Marizyme Sciences, Inc., Somaceutica, Inc., and Somahlution, Inc., and the secured parties signatory... (Filed With SEC on February 14, 2022)
Stock Option Agreement, dated January 16, 2021, between Marizyme, Inc. and Roger Schaller (Filed With SEC on February 14, 2022)
Form of Exchange Agreement between Marizyme, Inc. and the person executing the signature page thereto (Filed With SEC on December 27, 2021)
Form of Registration Rights Agreement between Marizyme, Inc. and the investors signatory thereto (Filed With SEC on December 27, 2021)
Form of Unit Purchase Agreement between Marizyme, Inc. and the investors signatory thereto (Filed With SEC on December 27, 2021)
MARIZYME, INC. SUBSCRIPTION AGREEMENT (Filed With SEC on July 3, 2019)
Form of Class C Common Stock Purchase Warrant issued by Marizyme, Inc., dated March 24, 2022 (Filed With SEC on May 16, 2022)
Form of 10% Secured Convertible Promissory Note issued by Marizyme, Inc., dated March 24, 2022 (Filed With SEC on May 16, 2022)
Common Stock Purchase Warrant issued to Bradley Richmond, dated February 14, 2022 (Filed With SEC on May 16, 2022)
Common Stock Purchase Warrant issued to Bradley Richmond, dated January 26, 2022 (Filed With SEC on May 16, 2022)
Agreement to Transfer Option and Amendatory Agreement, dated March 3, 2022, between Marizyme, Inc., James Sapirstein and Bevilacqua PLLC, as escrow agent (Filed With SEC on March 31, 2022)
Common Stock Purchase Warrant issued to Bradley Richmond, dated February 14, 2022 (Filed With SEC on March 31, 2022)
Common Stock Purchase Warrant issued to Bradley Richmond, dated January 26, 2022 (Filed With SEC on March 31, 2022)
Common Stock Purchase Warrant issued to Bradley Richmond, dated January 24, 2022 (Filed With SEC on February 14, 2022)
Common Stock Purchase Warrant issued to Univest Securities, LLC, dated January 24, 2022 (Filed With SEC on February 14, 2022)
Form of Security Agreement, dated as of May 25, 2021, between Marizyme, Inc. and the secured parties signatory thereto (Filed With SEC on February 14, 2022)
Form of Trademark Security Agreement, dated as of May 19, 2021, between Marizyme, Inc. and the secured parties signatory thereto (Filed With SEC on February 14, 2022)
Form of Patent Security Agreement, dated as of May 19, 2021, between Marizyme, Inc. and the secured parties signatory thereto (Filed With SEC on February 14, 2022)
Stock Option Agreement, dated January 29, 2021, between Marizyme, Inc. and Amy Chandler (Filed With SEC on February 14, 2022)
Stock Option Agreement with Terry Brostowin dated July 13, 2019 (Filed With SEC on February 14, 2022)
Common Stock Purchase Warrant issued to Bradley Richmond, dated October 2, 2020 (Filed With SEC on February 14, 2022)
Stock Option Agreement with James Sapirstein dated July 13, 2019 (Filed With SEC on February 14, 2022)
Stock Option Agreement with Frank Maresca dated July 13, 2019 (Filed With SEC on February 14, 2022)
Stock Option Agreement with Terry Brostowin dated December 6, 2018 (Filed With SEC on February 14, 2022)
Stock Option Agreement with James Sapirstein dated June 12, 2019 (Filed With SEC on February 14, 2022)
Stock Option Agreement with Frank Maresca dated January 9, 2020 (Filed With SEC on February 14, 2022)
Form of Class C Common Stock Purchase Warrant issued by Marizyme, Inc (Filed With SEC on December 27, 2021)
Form of 10% Secured Convertible Promissory Note issued by Marizyme, Inc (Filed With SEC on December 27, 2021)
Form of Class B Common Stock Purchase Warrant (Filed With SEC on August 23, 2021)
Form of 10% Secured Convertible Promissory Note Agreement (Filed With SEC on August 23, 2021)
Form of Unit Purchase Agreement, dated May 2021 (Filed With SEC on August 23, 2021)
Form of Placement Agent Warrant Agreement (Filed With SEC on August 23, 2021)
Form of Class A Common Stock Purchase Warrant (Filed With SEC on August 23, 2021)
SUBSCRIPTION AGREEMENT To subscribe for shares of Common Stock in the private offering of MARIZYME, INC. (Filed With SEC on August 14, 2020)
PLACEMENT AGENT WARRANT MARIZYME, INC. (Filed With SEC on August 14, 2020)
AMENDMENT NO. 3 TO ASSET PURCHASE AGREEMENT DATED DECEMBER 15, 2019 (Filed With SEC on August 5, 2020)
AMENDMENT 2 to the ASSET PURCHASE AGREEMENT Dated May 29, 2020 (Filed With SEC on June 5, 2020)
AMENDMENT 1 to the ASSET PURCHASE AGREEMENT Dated December 15, 2019 (Filed With SEC on June 5, 2020)
ASSET PURCHASE AGREEMENT (Filed With SEC on December 19, 2019)
MARIZYME, INC. COMMON SHARE PURCHASE WARRANT (Filed With SEC on July 3, 2019)